Literature DB >> 16758467

Passive catheter visualization in magnetic resonance-guided endovascular therapy using multicycle projection dephasers.

Jonathan N Draper1, M Louis Lauzon, Richard Frayne.   

Abstract

PURPOSE: To improve upon the conventional projection dephaser (PD) method of background suppression and evaluate the use of multicycle projection dephasers to improve catheter conspicuity in background-suppressed MR images.
MATERIALS AND METHODS: Passive visualization of endovascular catheters in MR images is compared using two background suppression techniques: 1) the conventional PD method and 2) the multicycle PD method. Contrast-filled 4-French (1.3 mm) catheters were imaged in homogeneous and heterogeneous phantoms, and in the common carotid artery of a canine using a modified spoiled gradient echo imaging sequence. We used catheter-to-background contrast (ranging from -100% to 100%) as the metric to compare background suppression techniques.
RESULTS: In the homogeneous and heterogeneous phantoms, the contrast was -6.9% (catheter darker than background) and 15.0%, respectively, using the conventional PD method, and 50.6% and 44.0%, respectively, using the multicycle PD method. In the canine carotid artery, the contrast was -3.1% using the conventional PD method and 53.0% using the multicycle PD method.
CONCLUSION: This work shows that multicycle projection dephasers improve catheter conspicuity over the conventional PD method. The multicycle PD method has potential for use in guiding endovascular procedures. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758467     DOI: 10.1002/jmri.20619

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  1 in total

1.  Control of intravascular catheters using an array of active steering coils.

Authors:  N Gudino; J A Heilman; J J Derakhshan; J L Sunshine; J L Duerk; M A Griswold
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.